Lymphoma, Mantle-Cell - 25 Studies Found
| Recruiting |
: Trial of Bortezomib, Cytarabine, and Dexamethasone in Mantle Cell Lymphoma : Mantle Cell Lymphoma : 2016-07-19 : Drug: Bortezomib, Cytarabine, Dexamethasone, Pegteograstim |
| Active, not recruiting |
: Phase II Study of Age‐Adjusted Rituximab, Bendamustine, Cytarabine as Induction Therapy in Older Patients With Mantle Cell Lymphoma : Mantle Cell Lymphoma : 2012-06-26 : Drug: Rituximab, Bendamustine, Cytarabine. 6 cycles of 28 days with Rituximab, Bendamustine and Cytarabi |
| Completed |
: Salvage Treatment With Lenalidomide and Dexamethaosne (LEN-DEX) in Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL) : MANTLE CELL LYMPHOMA : 2008-11-05 : Drug: Lenalidomide and Dexametasone Lenalidomide will be supplied as 5 mg and 25 mg capsules for oral ad |
| Terminated |
: Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell Lymphoma : Mantle Cell Lymphoma : 2009-02-18 : Drug: ZARNESTRA (Tipifarnib) |
| Completed |
: Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years : Mantle Cell Lymphoma : 2006-01-31 :
|